Aldebaran Capital’s ImageneBio Inc IMA Stock Holding History

Aldebaran Capital’s Portfolio IMA Stock Details IMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$107K	Sell	18,124 -442	-2%	-$2.5K	0.08%	39
2026 Q1	$92.8K	Sell	18,566 -504	-3%	-$3.27K	0.07%	43
2025 Q4	$132K	Sell	19,070 -492	-3%	-$3.65K	0.12%	34
2025 Q3	$159K	Sell	19,562 -614	-3%	-$8.14K	0.15%	32
2025 Q2	$324K	Sell	20,176 -474	-2%	-$6.96K	0.32%	30
2025 Q1	$317K	Buy	+20,650	New	+$356K	0.3%	32

Other funds holding IMA

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Trails Edge Capital Partners Atlanta, Georgia $630M AUM

BCM

BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

MIM

Monashee Investment Management Boston, Massachusetts $59.6M AUM 181.61% 1-Year Est. Return

Aldebaran Capital's IMA Position: Q2 2026 in Review

Aldebaran Capital reduced its ImageneBio Inc (IMA) stake by 2.4% in Q2 2026, selling an estimated $2.5K and leaving 18,124 shares worth $107K. The position accounts for 0.08% of the portfolio, ranked #39.

Aldebaran Capital first reported a position in IMA in Q1 2025 and has held it in 6 quarters since. The position peaked at $324K in Q2 2025. 35 funds tracked by Wall St. Rank hold IMA as of Q2 2026.

Aldebaran Capital held 18,124 shares of ImageneBio Inc worth $107K as of Q2 2026.
Aldebaran Capital sold 442 ImageneBio Inc shares in Q2 2026, an estimated $2.5K.
ImageneBio Inc made up 0.08% of Aldebaran Capital's portfolio in Q2 2026, its #39 holding.
Aldebaran Capital first reported a position in ImageneBio Inc in Q1 2025 and has held it in 6 quarters since.
Aldebaran Capital's ImageneBio Inc position peaked at $324K in Q2 2025.
35 funds tracked by Wall St. Rank held ImageneBio Inc as of Q2 2026.

Based on Aldebaran Capital's 13F filing for Q2 2026, filed 14 Aug 2026.